Occupational Medicines Market by Application (Chemical Poisoning, Psychological Disorder, Noise-Induced Hearing Loss & Vibration, Skin Disorder, Chronic Respiratory Disease, Pneumoconiosis, Musculoskeletal Disorder, Cancer, and Others), and Industry (Agriculture & Forestry, Construction, Manufacturing, Petroleum & Mining, Transportation, and Others) - Global Opportunity Analysis and Industry Forecast up to 2027
The occupational medicines market refers to the segment of the healthcare industry that focuses on providing medical services and solutions for workplace-related health issues. This includes the prevention, diagnosis, and treatment of work-related injuries and illnesses. Stringent occupational health and safety regulations implemented by governments and regulatory bodies across the world drive the demand for occupational medicines. Employers are required to provide a safe and healthy work environment for their employees, including appropriate medical surveillance and preventive measures. Compliance with these regulations necessitates the use of occupational medicines to assess and manage occupational hazards. On the other hand, the cost of implementing comprehensive occupational health programs and lack of awareness and education on occupational medicines may limit the market growth. Occupational Medicines Market is likely to grow at a rate of 6.6% CAGR by 2027.
Occupational Medicines market by Application
Chemical poisoning
Psychological disorder
Non-Induced hearing loss & vibration
Skin disorder
Chronic respiratory disease
Pneumoconiosis
Musculoskeletal disorder
Cancer
Occupational Medicines market by Industry
Agriculture & forestry
Construction
Manufacturing
Petroleum & mining
Transportation
Occupational Medicines Market by Geography
North America
Europe
Asia Pacific
Rest of the World
In the market for application, the Occupational Medicines market is segmented into Chemical poisoning, Psychological disorder, Non-Induced hearing loss & vibration, Skin disorder, chronic respiratory disease, Pneumoconiosis, Musculoskeletal disorder and Cancer. Among them the chronic respiratory disease segment is likely to hold the significant share in the market. This is accredited to the rising number of respiratory illnesses such as asthma, chronic obstructive pulmonary disease (COPD), and silicosis across the world. Work-related respiratory diseases are several illnesses caused by breathing in hazardous substances that damage the lungs, such as dust, fumes, and gases. Occupational lung disease has been adding to respiratory distress.
Key factors driving the occupational medicines market include:
Occupational Health and Safety Regulations: Governments and regulatory bodies across the world have implemented stringent occupational health and safety regulations to ensure worker safety. Compliance with these regulations necessitates the use of occupational medicines to prevent and treat work-related health conditions.
Growing Awareness: There is an increasing awareness among employers about the importance of maintaining a healthy workforce. Occupational medicines play a crucial role in promoting employee well-being, reducing absenteeism, and improving productivity.
Rising Incidence of Occupational Diseases: Work-related illnesses, such as respiratory disorders, musculoskeletal injuries, and chemical exposures, are on the rise. This has created a demand for occupational medicines that can address these specific health concerns.
Expansion of Industrial Sectors: As various industries continue to expand, the number of workers exposed to occupational hazards also increases. This further drives the need for occupational medicines to ensure employee health and safety.
Technological Advancements: Advancements in medical technology have led to the development of innovative diagnostic tools, treatments, and preventive measures for occupational diseases. This has contributed to the growth of the occupational medicines market.
The major leading companies of the Occupational Medicines market are Amgen Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Johnson & Johnson, Nestlй S.A. (Galderma S.A.), Novartis AG, Pfizer Inc., Sanofi.
The market for occupational medicines includes various products and services, such as medical examinations, health screenings, vaccinations, drug testing, and treatment of work-related injuries and illnesses. It encompasses both pharmaceutical products specific to occupational health and broader medical services provided by occupational health professionals.
It's important to note that market trends and dynamics can change over time. Therefore, for the most up-to-date information on the current state of the occupational medicines market, it is advisable to consult recent market research reports, industry publications, and reach out to relevant stakeholders in the occupational health sector.
Comprehensive overview of the global Occupational Medicines market restrains, opportunities, challenges, expected to drive its market growth.
The report provides the in-depth market segmentation along with the past, present and estimated market size in terms of volume and value.
This report presents the current industry trends and developments and the competitive outlook and strategies of key players and product offerings.
This report also depicts the SWOT analysis, portfolio analysis, capability analysis of the leading competitors.
Occupational Medicines market by Application
Chemical poisoning
Psychological disorder
Non-Induced hearing loss & vibration
Skin disorder
Chronic respiratory disease
Pneumoconiosis
Musculoskeletal disorder
Cancer
Occupational Medicines market by Industry
Agriculture & forestry
Construction
Manufacturing
Petroleum & mining
Transportation
Occupational Medicines Market by Geography
North America
Europe
Asia Pacific
Rest of the World
In the market for application, the Occupational Medicines market is segmented into Chemical poisoning, Psychological disorder, Non-Induced hearing loss & vibration, Skin disorder, chronic respiratory disease, Pneumoconiosis, Musculoskeletal disorder and Cancer. Among them the chronic respiratory disease segment is likely to hold the significant share in the market. This is accredited to the rising number of respiratory illnesses such as asthma, chronic obstructive pulmonary disease (COPD), and silicosis across the world. Work-related respiratory diseases are several illnesses caused by breathing in hazardous substances that damage the lungs, such as dust, fumes, and gases. Occupational lung disease has been adding to respiratory distress.
Key factors driving the occupational medicines market include:
Occupational Health and Safety Regulations: Governments and regulatory bodies across the world have implemented stringent occupational health and safety regulations to ensure worker safety. Compliance with these regulations necessitates the use of occupational medicines to prevent and treat work-related health conditions.
Growing Awareness: There is an increasing awareness among employers about the importance of maintaining a healthy workforce. Occupational medicines play a crucial role in promoting employee well-being, reducing absenteeism, and improving productivity.
Rising Incidence of Occupational Diseases: Work-related illnesses, such as respiratory disorders, musculoskeletal injuries, and chemical exposures, are on the rise. This has created a demand for occupational medicines that can address these specific health concerns.
Expansion of Industrial Sectors: As various industries continue to expand, the number of workers exposed to occupational hazards also increases. This further drives the need for occupational medicines to ensure employee health and safety.
Technological Advancements: Advancements in medical technology have led to the development of innovative diagnostic tools, treatments, and preventive measures for occupational diseases. This has contributed to the growth of the occupational medicines market.
The major leading companies of the Occupational Medicines market are Amgen Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Johnson & Johnson, Nestlй S.A. (Galderma S.A.), Novartis AG, Pfizer Inc., Sanofi.
The market for occupational medicines includes various products and services, such as medical examinations, health screenings, vaccinations, drug testing, and treatment of work-related injuries and illnesses. It encompasses both pharmaceutical products specific to occupational health and broader medical services provided by occupational health professionals.
It's important to note that market trends and dynamics can change over time. Therefore, for the most up-to-date information on the current state of the occupational medicines market, it is advisable to consult recent market research reports, industry publications, and reach out to relevant stakeholders in the occupational health sector.
Comprehensive overview of the global Occupational Medicines market restrains, opportunities, challenges, expected to drive its market growth.
The report provides the in-depth market segmentation along with the past, present and estimated market size in terms of volume and value.
This report presents the current industry trends and developments and the competitive outlook and strategies of key players and product offerings.
This report also depicts the SWOT analysis, portfolio analysis, capability analysis of the leading competitors.
1. EXECUTIVE SUMMARY
2. INDUSTRY OUTLOOK
2.1. Industry Overview
2.2. Industry Trends
3. MARKET SNAPSHOT
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. MARKET CHARACTERISTICS
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. APPLICATION: MARKET SIZE & ANALYSIS
5.1. Chemical poisoning
5.2. Psychological disorder
5.3. Non-Induced hearing loss & vibration
5.4. Skin disorder
5.5. Chronic respiratory disease
5.6. Pneumoconiosis
5.7. Musculoskeletal disorder
5.8. Cancer
6. INDUSTRY: MARKET SIZE & ANALYSIS
6.1. Agriculture & forestry
6.2. Construction
6.3. Manufacturing
6.4. Petroleum & mining
6.5. Transportation
7. GEOGRAPHY: MARKET SIZE & ANALYSIS
7.1. Overview
7.2. North America
7.3. Europe
7.4. Asia Pacific
7.5. Rest of the World
8. COMPETITIVE LANDSCAPE
8.1. Competitor Comparison Analysis
8.2. Market Developments
8.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
8.2.2. Product Launches and execution
9. VENDOR PROFILES
9.1. ELI LILLY AND COMPANY.
9.1.1. Overview
9.1.2. Financial Overview
9.1.3. Product Offerings
9.1.4. Developments
9.1.5. Business Strategy
9.2. ASTRAZENECA PLC,
9.2.1. Overview
9.2.2. Financial Overview
9.2.3. Product Offerings
9.2.4. Developments
9.2.5. Business Strategy
9.3. Novartis AG
9.3.1. Overview
9.3.2. Financial Overview
9.3.3. Product Offerings
9.3.4. Developments
9.3.5. Business Strategy
9.4. JOHNSON & JOHNSON.
9.4.1. Overview
9.4.2. Financial Overview
9.4.3. Product Offerings
9.4.4. Developments
9.4.5. Business Strategy
9.5. BRISTOL-MYERS SQUIBB COMPANY,
9.5.1. Overview
9.5.2. Financial Overview
9.5.3. Product Offerings
9.5.4. Developments
9.5.5. Business Strategy
9.5.6. Business Strategy
9.6. F. HOFFMANN-LA ROCHE LTD
9.6.1. Overview
9.6.2. Financial Overview
9.6.3. Product Offerings
9.6.4. Developments
9.6.5. Business Strategy
9.7. PFIZER IN
9.7.1. Overview
9.7.2. Financial Overview
9.7.3. Product Offerings
9.7.4. Developments
9.7.5. Business Strategy
9.8. Amgen Inc.
9.8.1. Overview
9.8.2. Financial Overview
9.8.3. Product Offerings
9.8.4. Developments
9.8.5. Business Strategy
9.9. SANOFI.
9.9.1. Overview
9.9.2. Financial Overview
9.9.3. Product Offerings
9.9.4. Developments
9.9.5. Business Strategy
9.10. Nestlй S.A
9.10.1. Overview
9.10.2. Financial Overview
9.10.3. Product Offerings
9.10.4. Developments
9.10.5. Business Strategy
10. ANALYST OPINION
11. ANNEXURE
11.1. Report Scope
11.2. Market Definitions
11.3. Research Methodology
11.3.1. Data Collation and In-house Estimation
11.3.2. Market Triangulation
11.3.3. Forecasting
11.4. Report Assumptions
11.5. Declarations
11.6. Stakeholders
11.7. Abbreviations
2. INDUSTRY OUTLOOK
2.1. Industry Overview
2.2. Industry Trends
3. MARKET SNAPSHOT
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. MARKET CHARACTERISTICS
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. APPLICATION: MARKET SIZE & ANALYSIS
5.1. Chemical poisoning
5.2. Psychological disorder
5.3. Non-Induced hearing loss & vibration
5.4. Skin disorder
5.5. Chronic respiratory disease
5.6. Pneumoconiosis
5.7. Musculoskeletal disorder
5.8. Cancer
6. INDUSTRY: MARKET SIZE & ANALYSIS
6.1. Agriculture & forestry
6.2. Construction
6.3. Manufacturing
6.4. Petroleum & mining
6.5. Transportation
7. GEOGRAPHY: MARKET SIZE & ANALYSIS
7.1. Overview
7.2. North America
7.3. Europe
7.4. Asia Pacific
7.5. Rest of the World
8. COMPETITIVE LANDSCAPE
8.1. Competitor Comparison Analysis
8.2. Market Developments
8.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
8.2.2. Product Launches and execution
9. VENDOR PROFILES
9.1. ELI LILLY AND COMPANY.
9.1.1. Overview
9.1.2. Financial Overview
9.1.3. Product Offerings
9.1.4. Developments
9.1.5. Business Strategy
9.2. ASTRAZENECA PLC,
9.2.1. Overview
9.2.2. Financial Overview
9.2.3. Product Offerings
9.2.4. Developments
9.2.5. Business Strategy
9.3. Novartis AG
9.3.1. Overview
9.3.2. Financial Overview
9.3.3. Product Offerings
9.3.4. Developments
9.3.5. Business Strategy
9.4. JOHNSON & JOHNSON.
9.4.1. Overview
9.4.2. Financial Overview
9.4.3. Product Offerings
9.4.4. Developments
9.4.5. Business Strategy
9.5. BRISTOL-MYERS SQUIBB COMPANY,
9.5.1. Overview
9.5.2. Financial Overview
9.5.3. Product Offerings
9.5.4. Developments
9.5.5. Business Strategy
9.5.6. Business Strategy
9.6. F. HOFFMANN-LA ROCHE LTD
9.6.1. Overview
9.6.2. Financial Overview
9.6.3. Product Offerings
9.6.4. Developments
9.6.5. Business Strategy
9.7. PFIZER IN
9.7.1. Overview
9.7.2. Financial Overview
9.7.3. Product Offerings
9.7.4. Developments
9.7.5. Business Strategy
9.8. Amgen Inc.
9.8.1. Overview
9.8.2. Financial Overview
9.8.3. Product Offerings
9.8.4. Developments
9.8.5. Business Strategy
9.9. SANOFI.
9.9.1. Overview
9.9.2. Financial Overview
9.9.3. Product Offerings
9.9.4. Developments
9.9.5. Business Strategy
9.10. Nestlй S.A
9.10.1. Overview
9.10.2. Financial Overview
9.10.3. Product Offerings
9.10.4. Developments
9.10.5. Business Strategy
10. ANALYST OPINION
11. ANNEXURE
11.1. Report Scope
11.2. Market Definitions
11.3. Research Methodology
11.3.1. Data Collation and In-house Estimation
11.3.2. Market Triangulation
11.3.3. Forecasting
11.4. Report Assumptions
11.5. Declarations
11.6. Stakeholders
11.7. Abbreviations
LIST OF TABLES
TABLE 1. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 2. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR CHEMICAL POISONING, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 3. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR PSYCHOLOGICAL DISORDER, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 4. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR NON-INDUCED HEARING LOSS & VIBRATION, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 5. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR SKIN DISORDER, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 6. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR CHRONIC RESPIRATORY DISEASE, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 7. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR PNEUMOCONIOSIS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 8. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR MUSCULOSKELETAL DISORDER, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 9. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR CANCER, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 10. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 11. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR AGRICULTURE & FORESTRY, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 12. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR CONSTRUCTION, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 13. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR MANUFACTURING, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 14. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR PETROLEUM & MINING, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 15. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR TRANSPORTATION, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 16. NORTH AMERICA OCCUPATIONAL MEDICINES MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
TABLE 17. NORTH AMERICA OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 18. NORTH AMERICA OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 19. U.S OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 20. U.S OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 21. CANADA OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 22. CANADA OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 23. EUROPE OCCUPATIONAL MEDICINES MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
TABLE 24. EUROPE OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 25. EUROPE OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 26. GERMANY OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 27. GERMANY OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 28. U.K OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 29. U.K OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 30. FRANCE OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION 2021-2027 (USD BILLION)
TABLE 31. FRANCE OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY 2021-2027 (USD BILLION)
TABLE 32. ITALY OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 33. ITALY OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 34. SPAIN OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 35. SPAIN OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 36. ROE OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 37. ROE OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 38. ASIA PACIFC OCCUPATIONAL MEDICINES MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
TABLE 39. ASIA PACIFC OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 40. ASIA PACIFC OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 41. CHINA OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 42. CHINA OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 43. INDIA OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 44. INDIA OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 45. JAPAN OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 46. JAPAN OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 47. REST OF APAC OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 48. REST OF APAC OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 49. REST OF WORLD OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 50. REST OF WORLD OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 51. SANOFI: FINANCIALS
TABLE 52. SANOFI: PRODUCTS & SERVICES
TABLE 53. SANOFI: RECENT DEVELOPMENTS
TABLE 54. PFIZER INC: FINANCIALS
TABLE 55. PFIZER INC: PRODUCTS & SERVICES
TABLE 56. PFIZER INC: RECENT DEVELOPMENTS
TABLE 57. ELI LILLY AND COMPANY: FINANCIALS
TABLE 58. ELI LILLY AND COMPANY: PRODUCTS & SERVICES
TABLE 59. ELI LILLY AND COMPANY: RECENT DEVELOPMENTS
TABLE 60. NOVARTIS AG: FINANCIALS
TABLE 61. NOVARTIS AG: PRODUCTS & SERVICES
TABLE 62. NOVARTIS AG: RECENT DEVELOPMENTS
TABLE 63. NESTLЙ S.A. (GALDERMA S.A.): FINANCIALS
TABLE 64. NESTLЙ S.A. (GALDERMA S.A.): PRODUCTS & SERVICES
TABLE 65. NESTLЙ S.A. (GALDERMA S.A.): RECENT DEVELOPMENTS
TABLE 66. ASTRAZENECA PLC: FINANCIALS
TABLE 67. ASTRAZENECA PLC: PRODUCTS & SERVICES
TABLE 68. ASTRAZENECA PLC: RECENT DEVELOPMENTS
TABLE 69. AMGEN INC.: FINANCIALS
TABLE 70. AMGEN INC: PRODUCTS & SERVICES
TABLE 71. AMGEN INC: RECENT DEVELOPMENTS
TABLE 72. F. HOFFMANN-LA ROCHE LTD: FINANCIALS
TABLE 73. F. HOFFMANN-LA ROCHE LTD: PRODUCTS & SERVICES
TABLE 74. F. HOFFMANN-LA ROCHE LTD: RECENT DEVELOPMENTS
TABLE 75. BRISTOL-MYERS SQUIBB COMPANY: FINANCIALS
TABLE 76. BRISTOL-MYERS SQUIBB COMPANY: PRODUCTS & SERVICES
TABLE 77. BRISTOL-MYERS SQUIBB COMPANY: RECENT DEVELOPMENTS
TABLE 78. JOHNSON & JOHNSON: FINANCIALS
TABLE 79. JOHNSON & JOHNSON: PRODUCTS & SERVICES
TABLE 80. JOHNSON & JOHNSON: RECENT DEVELOPMENTS
TABLE 81. TEVA PHARMACEUTICAL INDUSTRIES LTD: FINANCIALS
TABLE 82. TEVA PHARMACEUTICAL INDUSTRIES LTD: PRODUCTS & SERVICES
TABLE 83. TEVA PHARMACEUTICAL INDUSTRIES LTD: RECENT DEVELOPMENTS
TABLE 1. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 2. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR CHEMICAL POISONING, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 3. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR PSYCHOLOGICAL DISORDER, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 4. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR NON-INDUCED HEARING LOSS & VIBRATION, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 5. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR SKIN DISORDER, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 6. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR CHRONIC RESPIRATORY DISEASE, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 7. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR PNEUMOCONIOSIS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 8. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR MUSCULOSKELETAL DISORDER, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 9. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR CANCER, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 10. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 11. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR AGRICULTURE & FORESTRY, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 12. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR CONSTRUCTION, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 13. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR MANUFACTURING, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 14. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR PETROLEUM & MINING, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 15. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR TRANSPORTATION, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 16. NORTH AMERICA OCCUPATIONAL MEDICINES MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
TABLE 17. NORTH AMERICA OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 18. NORTH AMERICA OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 19. U.S OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 20. U.S OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 21. CANADA OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 22. CANADA OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 23. EUROPE OCCUPATIONAL MEDICINES MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
TABLE 24. EUROPE OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 25. EUROPE OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 26. GERMANY OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 27. GERMANY OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 28. U.K OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 29. U.K OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 30. FRANCE OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION 2021-2027 (USD BILLION)
TABLE 31. FRANCE OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY 2021-2027 (USD BILLION)
TABLE 32. ITALY OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 33. ITALY OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 34. SPAIN OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 35. SPAIN OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 36. ROE OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 37. ROE OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 38. ASIA PACIFC OCCUPATIONAL MEDICINES MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
TABLE 39. ASIA PACIFC OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 40. ASIA PACIFC OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 41. CHINA OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 42. CHINA OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 43. INDIA OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 44. INDIA OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 45. JAPAN OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 46. JAPAN OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 47. REST OF APAC OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 48. REST OF APAC OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 49. REST OF WORLD OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 50. REST OF WORLD OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 51. SANOFI: FINANCIALS
TABLE 52. SANOFI: PRODUCTS & SERVICES
TABLE 53. SANOFI: RECENT DEVELOPMENTS
TABLE 54. PFIZER INC: FINANCIALS
TABLE 55. PFIZER INC: PRODUCTS & SERVICES
TABLE 56. PFIZER INC: RECENT DEVELOPMENTS
TABLE 57. ELI LILLY AND COMPANY: FINANCIALS
TABLE 58. ELI LILLY AND COMPANY: PRODUCTS & SERVICES
TABLE 59. ELI LILLY AND COMPANY: RECENT DEVELOPMENTS
TABLE 60. NOVARTIS AG: FINANCIALS
TABLE 61. NOVARTIS AG: PRODUCTS & SERVICES
TABLE 62. NOVARTIS AG: RECENT DEVELOPMENTS
TABLE 63. NESTLЙ S.A. (GALDERMA S.A.): FINANCIALS
TABLE 64. NESTLЙ S.A. (GALDERMA S.A.): PRODUCTS & SERVICES
TABLE 65. NESTLЙ S.A. (GALDERMA S.A.): RECENT DEVELOPMENTS
TABLE 66. ASTRAZENECA PLC: FINANCIALS
TABLE 67. ASTRAZENECA PLC: PRODUCTS & SERVICES
TABLE 68. ASTRAZENECA PLC: RECENT DEVELOPMENTS
TABLE 69. AMGEN INC.: FINANCIALS
TABLE 70. AMGEN INC: PRODUCTS & SERVICES
TABLE 71. AMGEN INC: RECENT DEVELOPMENTS
TABLE 72. F. HOFFMANN-LA ROCHE LTD: FINANCIALS
TABLE 73. F. HOFFMANN-LA ROCHE LTD: PRODUCTS & SERVICES
TABLE 74. F. HOFFMANN-LA ROCHE LTD: RECENT DEVELOPMENTS
TABLE 75. BRISTOL-MYERS SQUIBB COMPANY: FINANCIALS
TABLE 76. BRISTOL-MYERS SQUIBB COMPANY: PRODUCTS & SERVICES
TABLE 77. BRISTOL-MYERS SQUIBB COMPANY: RECENT DEVELOPMENTS
TABLE 78. JOHNSON & JOHNSON: FINANCIALS
TABLE 79. JOHNSON & JOHNSON: PRODUCTS & SERVICES
TABLE 80. JOHNSON & JOHNSON: RECENT DEVELOPMENTS
TABLE 81. TEVA PHARMACEUTICAL INDUSTRIES LTD: FINANCIALS
TABLE 82. TEVA PHARMACEUTICAL INDUSTRIES LTD: PRODUCTS & SERVICES
TABLE 83. TEVA PHARMACEUTICAL INDUSTRIES LTD: RECENT DEVELOPMENTS
